The California Nanosystems Institute at University of California, Los Angeles (UCLA) Purchases Preclinical Optical Molecular Imaging System From ART Advanced Research Technologies Inc.

MONTREAL, CANADA--(Marketwire - September 10, 2008) - ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce the sale of the optical molecular imaging Optix® MX2 system to the California NanoSystems Institute (CNSI) at UCLA, in Los Angeles.